title: Symptomatic lobar intracerebral haemorrhage preceded by transient focal neurological episodes.
abstract: We report the case of a symptomatic intracerebral haemorrhage (ICH) in an elderly woman, secondary to cerebral amyloid angiopathy (CAA), and present the relevant imaging. A few months before, our patient experienced multiple, stereotyped, brief episodes of spreading paraesthesias, which were considered to be transient ischaemic attacks (TIAs) and treated with antithrombotic agents. In this case report, we explore CAA, a highly prevalent but under-recognised form of small vessel cerebrovascular disease and common cause of ICH. We then briefly discuss the clinical significance of transient focal neurological episodes in the context of CAA, as potential warning signs of future ICH. An important clinical message is that misdiagnosis of CAA-related focal neurological symptoms as TIAs (and prescribing antithrombotic drugs) could lead to potentially avoidable ICH. We also provide the current evidence base for the acute and secondary prevention treatment of patients with lobar ICH attributed to CAA, and discuss the prognosis.
authors: Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
authors: Robert
authors: R
authors: Hurford
authors: Andreas
authors: A
authors: Charidimou
authors: David
authors: D
authors: Werring
mesh_terms: D000368:Aged; D001921:Brain / Q000473:pathology*; D016657:Cerebral Amyloid Angiopathy / Q000150:complications / Q000175:diagnosis*; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D003951:Diagnostic Errors / Q000009:adverse effects; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D005343:Fibrinolytic Agents
references: Neurology. 2000 Oct 10;55(7):947-51
references: 11061249
references: Lancet. 2009 May 9;373(9675):1632-44
references: 19427958
references: Neurology. 1993 Oct;43(10):2073-9
references: 8413970
references: J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):124-37
references: 22056963
references: Int J Stroke. 2013 Feb;8(2):105-8
references: 23336261
references: Cerebrovasc Dis. 2003;15(1-2):29-36
references: 12499708
references: Neurology. 2010 Apr 27;74(17):1346-50
references: 20421578
references: Neurology. 2001 Feb 27;56(4):537-9
references: 11222803
references: Stroke. 2011 Jan;42(1):227-76
references: 20966421
references: J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):275-81
references: 22056966
references: Stroke. 2012 Sep;43(9):2324-30
references: 22798323
references: Stroke. 1995 Aug;26(8):1471-7
references: 7631356
references: Stroke. 2010 Feb;41(2):394-6
references: 20044530
references: Neurology. 2006 Apr 25;66(8):1144-52
references: 16636229
references: Lancet Neurol. 2008 May;7(5):391-9
references: 18396107
references: Lancet. 2007 Jan 27;369(9558):306-18
references: 17258671
references: J Neurol Sci. 2010 Dec 15;299(1-2):66-71
references: 20850797
references: Trials. 2011 May 17;12:124
references: 21586127
references: Eur J Neurol. 2011 Apr;18(4):597-603
references: 21040231
references: AJNR Am J Neuroradiol. 2008 Jan;29(1):184-6
references: 17947366
references: Stroke. 1999 Jan;30(1):29-33
references: 9880384
references: Cerebrovasc Dis. 2005;20(5):412-4
references: 16210853